越南淋病奈瑟菌2011年与2015-16年分离株的基因组分析与抗菌药物耐药性
2015-16年分离株对环丙沙星耐药率达100%,15%为多重耐药,27%携带嵌合penA等位基因,而2011年未发现嵌合penA。研究提示越南淋球菌耐药性增加,嵌合penA克隆传入导致头孢克肟耐药上升。
要点
- 2015-16年越南淋球菌对环丙沙星耐药率100%,四环素79%,青霉素50%。
- 27%的2015-16年分离株携带嵌合penA等位基因,2011年分离株均无。
- 2011至2015-16年除头孢曲松、大观霉素和四环素外,其他抗菌药物耐药性均增加。
核心结论
- 2011至2015-16年越南淋球菌对当前和既往使用的大多数抗菌药物耐药性增加,但头孢曲松、大观霉素和四环素除外。
- 2011年后传入两个携带嵌合penA的克隆,可解释头孢克肟耐药性增加。
研究设计与样本
- 采用Etest进行抗菌药物敏感性试验,并使用Illumina MiSeq进行全基因组测序及耐药决定簇检测。
主要发现
- 2015-16年分离株耐药率:环丙沙星100%、四环素79%、苄青霉素50%、头孢克肟15%、头孢曲松1%、大观霉素0%,5%对阿奇霉素非野生型。
- 庆大霉素MIC范围为2-8 mg/L。
- 2015-16年分离株中27%(n=33)携带嵌合penA等位基因,2011年分离株无嵌合penA等位基因。
- 系统发育基因组分析显示2011年后传入两个含嵌合penA的克隆(penA-10.001和penA-34.001),与在日本和欧洲传播的头孢克肟耐药株相关,以及一个与XDR株WHO Q相对相似的小分支(8株)。
临床怎么用
- 越南淋球菌耐药性增加,需加强抗菌药物耐药监测和抗菌药物管理。
- 建议使用全基因组测序进行淋球菌分子流行病学和耐药性预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Antimicrobial resistance (AMR) in Neisseria gonorrhoeae, compromising gonorrhoea treatment, is a threat to reproductive health globally. South-East and East Asia have been major sources of emergence and subsequent international spread of AMR gonococcal strains during recent decades. We investigated gonococcal isolates from 2011 and 2015-16 in Vietnam using AMR testing, WGS and detection of AMR determinants. METHODS: Two hundred and twenty-nine gonococcal isolates cultured in 2015-16 (n = 121) and 2011 (n = 108) in Vietnam were examined. AMR testing was performed using Etest and WGS with Illumina MiSeq. RESULTS: Resistance among the 2015-16 isolates was as follows: ciprofloxacin, 100%; tetracycline, 79%; benzylpenicillin, 50%; cefixime, 15%; ceftriaxone, 1%; spectinomycin, 0%; and 5% were non-WT to azithromycin. Eighteen (15%) isolates were MDR. The MIC range for gentamicin was 2-8 mg/L. Among the 2015-16 isolates, 27% (n = 33) contained a mosaic penA allele, while no isolates had a mosaic penA allele in 2011. Phylogenomic analysis revealed introduction after 2011 of two mosaic penA-containing clones (penA-10.001 and penA-34.001), which were related to cefixime-resistant strains spreading in Japan and Europe, and a minor clade (eight isolates) relatively similar to the XDR strain WHO Q. CONCLUSIONS: From 2011 to 2015-16, resistance in gonococci from Vietnam increased to all currently and previously used antimicrobials except ceftriaxone, spectinomycin and tetracycline. Two mosaic penA-containing clones were introduced after 2011, explaining the increased cefixime resistance. Significantly increased AMR surveillance, antimicrobial stewardship and use of WGS for molecular epidemiology and AMR prediction for gonococcal isolates in Vietnam and other Asian countries are crucial.
引用
- Lan PT, Golparian D, Ringlander J, et al. Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16. J Antimicrob Chemother. 2020. PMID: 32068837. doi:10.1093/jac/dkaa040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。